Although most stocks made forward progress in January, a few of them bucked the bigger trend for understandable reasons.

Brian Hartigan, Invesco, joins 'Fast Money' to talk the Nasdaq-100 turning 40, what's ahead for tech investing and more.

The US indices continue to be somewhat mixed in the early hours of Wednesday, as the markets are waiting for more inflation ...

The Nasdaq-100 should not be confused with the Nasdaq Composite® Index. The Nasdaq Composite Index represents every company ...

If the bulls hold above last Monday’s low at $21008 and especially the January 13 low at $20538, they remain in charge, and a ...

Below, I'll go over how a $50,000 investment into this ETF might grow over the long haul, and whether it can get to $1 ...

This fund has a lot going for it. But is the valuation too high? The post The pros and cons of buying Betashares Nasdaq 100 ...

The rally began in late January, following CEO Zuckerberg's announcement of ambitious plans to spend over $60 billion this ...

If you're interested in broad exposure to the Large Cap Growth segment of the US equity market, look no further than the Invesco NASDAQ 100 ETF (QQQM), a passively managed exchange traded fund ...

In early trading on Thursday, shares of AstraZeneca topped the list of the day's best performing components of the Nasdaq 100 index, trading up 4.4%. Year to date, AstraZeneca registers a 13.0% gain.

Follow along for live updates on stocks and other markets, including the Dow Jones Industrial Average, S&P 500 and Nasdaq Composite.